⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplementary Methods from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis

Joe‐Elie Salem Marie Bretagne Baptiste Abbar Sarah Léonard-Louis Stéphane Éderhy Alban Redheuil Samia Boussouar Lee S. Nguyen Adrien Procureur Frederic Stein Charlotte Fenioux Perrine Devos Paul Gougis Martin Dres Alexandre Demoule Dimitri Psimaras Timothée Lenglet Thierry Maisonobe Marc Pineton de Chambrun Guillaume Hékimian Christian Straus Jésus Gonzalez‐Bermejo David Klatzmann Aude Rigolet Perrine Guillaume-Jugnot Nicolas Champtiaux Olivier Benvéniste Nicolas Weiss Samir Saheb Philippe Rouvier Isabelle Plu Estelle Gandjbakhch Mathieu Kernéis Nadjib Hammoudi Noël Zahr Claudia Llontop Capucine Morélot‐Panzini Lorenz Lehmann Juan Qin Javid J. Moslehi Michèlle Rosenzwajg Thomas Similowski Yves Allenbach

View at Publisher

Ask AI

Bookmark

Share

Abstract

Methods concerning Immune-checkpoint proteins profiling on peripheral blood mononuclear cells and Circulating immune checkpoint agents drug monitoring

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Salem et al. (2024) studied this question.

synapsesocial.com/papers/68e587eeb6db643587523d72 https://doi.org/10.1158/2159-8290.27025073

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Methods from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis2024
2Figure S4 from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis2024
3Table S6 from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis2024
4Table S6 from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis2024
5Table S2 from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis2024

More related papers

Table S2 from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis2024
Figure S2 from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis2024
Table S3 from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis2024